Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Drug Trials & The Media - Media coverage of controversial HIV drug trials

24.08.2005


Media reports of drug trials can lack accuracy and reliability, according to a study published in the open access journal BMC International Health and Human Rights. Researchers say that in controversial issues such as HIV/AIDS prevention drug trials, investigators and funders should engage with the media to avoid misinterpretation and inaccurate reporting.



The governments of Cameroon and Cambodia cancelled planned trials for the antiretroviral drug tenofovir in 2004 following activist group pressure. The trials, to investigate the use of tenofovir to prevent HIV infection, and their subsequent closure, were widely covered by the international media. Edward Mills, from McMaster University in Canada, and colleagues from the USA and the UK found that media reports were largely inconsistent and failed to seek primary sources for information.

Mills and colleagues studied all media reports on the closure of the two trials for tenofovir. Their study reveals that the reasons for the closure given by the media varied greatly and were sometimes entirely incorrect. The concerns expressed by activists and consistently reported in the press included: a lack of medical insurance for trial related injuries, human rights considerations, and inadequate care for people who contract HIV during the trial.


The researchers found that out of the 36 articles about the trials that they studied more in depth, 17 did not identify a primary source of information, only 7 reported having interviewed a trial investigator or representative and only one reported having interviewed a participant to the trial. Only one report included interviews of both trial investigators and opponents to the trials.

This study suggests that seeking reliable primary sources of information might have enabled journalists to report more accurately on the issues surrounding the trials. But the researchers make clear it is as much the responsibility of the organisers of such trials to provide accurate information to the media and the public.

"Given the potential impact of the media in formulation of health policy related to HIV, efforts are needed to effectively engage the media during periods of controversy in the HIV/AIDS epidemic", write the authors.

Juliette Savin | alfa
Further information:
http://www.biomedcentral.com

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

A Nano-Roundabout for Light

09.12.2016 | Physics and Astronomy

Further Improvement of Qubit Lifetime for Quantum Computers

09.12.2016 | Physics and Astronomy

New weapon against Diabetes

09.12.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>